Large-scale testing (Phase 3)WithdrawnNCT04006691
What this trial is testing
Efficacy and Safety of UGN-101 in Recurrent Patients
Who this might be right for
CarcinomaTransitional Cell CarcinomaTransitional Cell Cancer of the Renal Pelvis and Ureter
UroGen Pharma Ltd.